Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Artigo
|
![]() |
Disitamab vedotin/enfortumab vedotin/pembrolizumab: Lack of efficacy and hypoesthesiaReactions weekly, 2024-07 (2015), p.152-152Auckland: Springer Nature B.VTexto completo disponível |
2 |
Material Type: Artigo
|
![]() |
Multiple drugsReactions weekly, 2021-12 (1886), p.296-296Auckland: Springer Nature B.VTexto completo disponível |
3 |
Material Type: Artigo
|
![]() |
Ipilimumab/nivolumab: Immunotherapy-related hypophysitis: case reportReactions weekly, 2021-11 (1881), p.147-147Auckland: Springer Nature B.VTexto completo disponível |
4 |
Material Type: Artigo
|
![]() |
Ipilimumab/nivolumab: Hepatotoxicity in the form of cholestatic liver injury: case reportReactions weekly, 2021-10 (1878), p.283-283Auckland: Springer Nature B.VTexto completo disponível |
5 |
Material Type: Artigo
|
![]() |
Atezolizumab/bevacizumab/methylprednisolone Pneumonitis and lack of efficacy: case reportReactions weekly, 2021-07 (1862), p.79-79Auckland: Springer Nature B.VTexto completo disponível |
6 |
Material Type: Artigo
|
![]() |
Multiple drugs: Lack of efficacy and various toxicities: 19 case reportsReactions weekly, 2021-05 (1856), p.291-291Auckland: Springer Nature B.VTexto completo disponível |
7 |
Material Type: Artigo
|
![]() |
Methylprednisolone Lack of efficacy: case reportReactions weekly, 2021-01 (1836), p.495-495Auckland: Springer Nature B.VTexto completo disponível |
8 |
Material Type: Artigo
|
![]() |
Immunotherapy-related cutaneous AEs respond to treatmentsReactions weekly, 2019-07 (1760), p.8-8Auckland: Springer Nature B.VTexto completo disponível |
9 |
Material Type: Artigo
|
![]() |
Higher than expected ADR rates with immune checkpoint inhibitorsReactions weekly, 2018-12 (1730), p.11-11Auckland: Springer Nature B.VTexto completo disponível |
10 |
Material Type: Artigo
|
![]() |
Atezolizumab/nivolumab/pembrolizumab Tumour pseudoprogression and hyperprogression: 16 case reportsReactions weekly, 2023-01 (1941), p.78-78Auckland: Springer Nature B.VTexto completo disponível |